FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 90 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,129,113 | +86.0% | 4,308,359 | +38.2% | 1.34% | +56.9% |
| Q2 2023 | $10,286,086 | +65.9% | 3,116,996 | +43.2% | 0.85% | +17.2% |
| Q1 2023 | $6,201,728 | -37.4% | 2,176,045 | +59.9% | 0.73% | -29.7% |
| Q4 2022 | $9,909,310 | -47.8% | 1,361,169 | -42.0% | 1.04% | -43.0% |
| Q3 2022 | $18,995,000 | +62.5% | 2,347,989 | -1.6% | 1.82% | +60.9% |
| Q2 2022 | $11,691,000 | -85.7% | 2,385,885 | -30.9% | 1.13% | -85.6% |
| Q1 2022 | $81,672,000 | +85.5% | 3,453,371 | +121.3% | 7.86% | +276.8% |
| Q3 2021 | $44,023,000 | +218.3% | 1,560,563 | +18.2% | 2.09% | +188.9% |
| Q2 2021 | $13,832,000 | +33.2% | 1,319,887 | +49.7% | 0.72% | +1.1% |
| Q1 2021 | $10,388,000 | – | 881,832 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |